Interleukin-2 (Roussel Uclaf)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-2 (Roussel Uclaf)
Drug Alias NameIL-2 (Roussel Uclaf)RU-49637U-49637
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene SaSanofi
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A